V160F (p.Val160Phe) variant of SLC40A1 (Ferroportin)

V160F (p.Val160Phe) in SLC40A1 (Ferroportin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hemochromatosis type 4. The available variant effect predictions contribute to a CATVariant prioritization score of 0.88 / 1. The record also includes structural context.

V160F (p.Val160Phe) variant details